Skip to main content

XVA desks target capital in optimisation runs

US regulatory uncertainty leaves banks cautious on investing in new optimisation tools, Risk Benchmarking study finds

This piece is part of a series benchmarking bank XVA management practices. Risk Management subscribers can view selected cuts of the underlying data here.

A majority of banks treat reducing the impact of regulatory capital as a priority when optimising derivatives valuation adjustments (XVAs), yet only a handful are exploring new tools to help squash it during optimisation runs, the findings of Ri

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Want to know what’s included in our free membership? Click here

Show password
Hide password

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here